EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Venous thrombotic events in severe and critically COVID-19 patients despite high dose prophylactic low-molecular-weight heparin

Chantal Visser, Reinier A Sprenger, Hans J van den Bout, Dirk P Boer, Rachida El Moussaoui, Jan G den Hollander

Thrombosis Update · 2020

DOI: 10.1016/j.tru.2020.100006 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Thrombosis Update, 2020. Verfasst von Chantal Visser und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Maasstad Hospital, Locatiecode 1L3024, Postbus 9100, 3007 AC, Rotterdam, the Netherlands. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypercoagulation is one of the most distinct prognostic factors of patients with COVID-19 and has been associated with arterial thrombosis and other venous thrombotic events (VTE). Bleeding complications are far less encountered. The International Society on Thrombosis and Haemostasis (ISTH) guidance advises giving prophylactic low-molecular-weight heparin (LMWH) to prevent these events, although there is evidence that the incidence remains high despite using prophylactic LMWH. We describe three cases of COVID-19 pneumonia that were admitted to our intensive care unit (ICU) and developed acute pulmonary embolisms (APE) despite high dosage prophylactic LMWH. These cases raise concerns about using prophylactic LMWH instead of therapeutic anticoagulation in severe and critically COVID-19 patients.

Schlagwörter

Stichwörter der Autor:innen

AnticoagulantsBlood CoagulationCOVID-19HeparinLow-molecular-weightPulmonary embolism

Autor:innen und Institutionen

  • Department of Internal Medicine, Maasstad Hospital, Locatiecode 1L3024, Postbus 9100, 3007 AC, Rotterdam, the Netherlands.
  • Department of Intensive Care, Maasstad Hospital, Locatiecode 1L3024, Postbus 9100, 3007 AC, Rotterdam, the Netherlands.

Zitieren

APA

Visser, C., Sprenger, R. A., van den Bout, H. J., Boer, D. P., El Moussaoui, R., & den Hollander, J. G. (2020). Venous thrombotic events in severe and critically COVID-19 patients despite high dose prophylactic low-molecular-weight heparin. Thrombosis Update. https://doi.org/10.1016/j.tru.2020.100006

Vancouver

Visser C, Sprenger RA, van den Bout HJ, Boer DP, El Moussaoui R, den Hollander JG. Venous thrombotic events in severe and critically COVID-19 patients despite high dose prophylactic low-molecular-weight heparin. Thrombosis Update. 2020. doi:10.1016/j.tru.2020.100006

BibTeX
@article{Visser2020,
  author = {Visser, Chantal and Sprenger, Reinier A and van den Bout, Hans J and Boer, Dirk P and El Moussaoui, Rachida and den Hollander, Jan G},
  title = {Venous thrombotic events in severe and critically COVID-19 patients despite high dose prophylactic low-molecular-weight heparin},
  journal = {Thrombosis Update},
  year = {2020},
  doi = {10.1016/j.tru.2020.100006}
}
Kostenlos starten →